Is there a role for insulin-like growth factor inhibition in the treatment of COVID-19-related adult respiratory distress syndrome?
Author:
Funder
Research to Prevent Blindness
National Eye Institute
Publisher
Elsevier BV
Subject
General Medicine
Reference16 articles.
1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020
2. Past and present ARDS mortality rates: A systematic review;Máca;Respir Care,2017
3. National incidence rates for Acute Respiratory Distress Syndrome (ARDS) and ARDS cause-specific factors in the United States (2006–2014);Eworuke;J Crit Care,2018
4. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020
5. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?;Liu;J Autoimmun,2019
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Increased galanin-galanin receptor 1 signaling, inflammation, and insulin resistance are associated with affective symptoms and chronic fatigue syndrome due to Long COVID;2024-04-26
2. Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease;Communications Medicine;2023-04-12
3. Deep autoencoder for interpretable tissue-adaptive deconvolution and cell-type-specific gene analysis;Nature Communications;2022-11-08
4. Therapeutic prospects of ceRNAs in COVID-19;Frontiers in Cellular and Infection Microbiology;2022-09-20
5. Inhibitors of Activin Receptor-like Kinase 5 Interfere with SARS-CoV-2 S-Protein Processing and Spike-Mediated Cell Fusion via Attenuation of Furin Expression;Viruses;2022-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3